Skip to content
Bomb Report – Lifestyle
Author:
Biovica International
New AACR Data Expand Evidence for TKa In Immunotherapy-Treated Patients and CDK Inhibitor Dose Optimization
March 18, 2026
Nomination Committee for Biovica International AB for the 2026 Annual General Meeting
March 9, 2026
Biovica Announces Planned CEO Succession; Anders Rylander to Step Down During 2026
March 7, 2026
←
Previous Page
1
2
3